answer text |
<p>The Department of Energy Security and Net Zero is delivering the up to £6 million
Medical Radionuclide Innovation Programme (MRIP) which aims to identify technology
and policy options that could support domestic supply of medical radionuclides in
the future.</p><p>MRIP launched in December 2022 and will run until March 2025.</p><p>The
programme will deliver an assessment of the UK supply and demand landscape, building
on existing research. It will test data against potential future scenarios to inform
policy development and future Government decision-making. Officials are currently
finalising Phase I of the Landscape Assessment, with Phase II commencing next financial
year to focus on modelling future supply and demand scenarios.</p><p>In parallel,
several feasibility studies are ongoing by the Nuclear Decommissioning Authority to
assess whether the retrieval of radionuclides from legacy material is possible, and
whether this material might be useful in supporting domestic supply and research.</p><p>The
Innovation Project Call aims to spark innovation in the field and the competitive
call will commence later this year. The call aims to spark innovation across the supply
chain, to develop new radionuclide production capability in the UK.</p>
|
|